Lipocine Inc.
LPCN
$3.09
-$0.16-4.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.32M | 4.21M | 3.67M | 11.20M | 7.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.32M | 4.21M | 3.67M | 11.20M | 7.92M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 4.32M | 4.21M | 3.67M | 11.20M | 7.92M |
| SG&A Expenses | 3.65M | 3.93M | 4.55M | 5.00M | 5.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.63M | 9.79M | 10.14M | 12.35M | 13.22M |
| Operating Income | -6.31M | -5.58M | -6.47M | -1.16M | -5.29M |
| Income Before Tax | -5.48M | -4.51M | -5.37M | 9.00K | -4.05M |
| Income Tax Expenses | 200.00 | 200.00 | 700.00 | 700.00 | 1.30K |
| Earnings from Continuing Operations | -5.48 | -4.51 | -5.37 | 0.01 | -4.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.48M | -4.51M | -5.37M | 8.40K | -4.06M |
| EBIT | -6.31M | -5.58M | -6.47M | -1.16M | -5.29M |
| EBITDA | -6.25M | -5.52M | -6.42M | -1.11M | -5.26M |
| EPS Basic | -1.02 | -0.84 | -1.00 | 0.01 | -0.76 |
| Normalized Basic EPS | -0.64 | -0.53 | -0.63 | 0.00 | -0.47 |
| EPS Diluted | -1.04 | -0.89 | -1.05 | -0.04 | -0.79 |
| Normalized Diluted EPS | -0.65 | -0.54 | -0.64 | -0.01 | -0.48 |
| Average Basic Shares Outstanding | 21.46M | 21.40M | 21.39M | 21.36M | 21.32M |
| Average Diluted Shares Outstanding | 21.80M | 21.73M | 21.72M | 21.73M | 21.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |